Global Cannabidiol Market to Reach $4.14B by 2030

The public perception of cannabidiol is positive, with 64% of American respondents thinking cannabidiol is helpful, according to a Delvens survey.
The public perception of cannabidiol is positive, with 64% of American respondents thinking cannabidiol is helpful, according to a Delvens survey.

The global cannabidiol market is expected to reach $4.14 billion by 2030 from $1.92 billion in 2021, according to a report by Delvens. The market has expanded at a CAGR of 9.7%.

Cannabidiol, along with other cannabinoids and terpenoids, will eventually be accepted as a component of standard consumer goods in the medium to long term.

According to the report, cannabidiol "will become a common ingredient in F&B, dietary supplements, and personal care products in the days ahead with the resolution of regulatory issues."

The public perception of cannabidiol is positive, with 64% of American respondents thinking cannabidiol is helpful, according to a Delvens survey.

More than 40% of nonusers say they "probably will" or "definitely will" buy a cannabis beauty product in the upcoming six months, although only 20% of targeted consumers had used CBD in the previous six months.

A variety of health advantages associated with cannabidiol are also of interest to consumers.

Due to FDA regulation of cannabidiol in food and beverage items, cannabidiol topical treatments, which presently make up about 25% of the cannabidiol category, are anticipated to overtake ingestible in market share.

Major players in the market are: 

  • ENDOCA
  • Cannoid, LLC
  • Medical Marijuana, Inc.
  • Folium Biosciences
  • Elixinol
  • NuLeaf Naturals, LLC
  • Isodiol International, Inc.
  • Pharmahemp d.o.o.
More in Trends